Nykredit A/S’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$391M Buy
337,792
+10,204
+3% +$12M 1.42% 9
2026
Q2
$393M Buy
+327,588
New +$335M 1.5% 8

Other funds holding LLY

Nykredit A/S's LLY Position: Q3 2026 in Review

Nykredit A/S increased its Eli Lilly (LLY) stake by 3.1% in Q3 2026, buying an estimated $12M and bringing the position to 337,792 shares worth $391M. The position accounts for 1.42% of the portfolio, ranked #9.

Nykredit A/S first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $393M in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Nykredit A/S held 337,792 shares of Eli Lilly worth $391M as of Q3 2026.
  • Nykredit A/S bought 10,204 Eli Lilly shares in Q3 2026, an estimated $12M.
  • Eli Lilly made up 1.42% of Nykredit A/S's portfolio in Q3 2026, its #9 holding.
  • Nykredit A/S first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • Nykredit A/S's Eli Lilly position peaked at $393M in Q2 2026.
  • 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Nykredit A/S's 13F filing for Q3 2026, filed 6 Nov 2026.